… nervous system protected the newborn, especially the preterm infant, from experiencing pain.
In … and metabolism of intravenous midazolam in preterm infants. Clinical Pharmacology & …

… preterm neonates between 24 and 32 weeks’ gestational age. Despite the availability of
these PK data, intravenous … Concerning sedatives, direct links between midazolam exposure …

… Morphine pharmacodynamics in mechanically ventilated preterm neonates undergoing …
The aim of the study was to investigate the pharmacokinetics of midazolam, after intravenous …

… sildenafil in premature infants following both intravenous and … PK in 2 cohorts of premature
infants; the first group was … received a single dose of intravenous (IV) sildenafil for the purpose …

… preterm neonates, and several examples of adverse events due to immature DME have been
reported (eg, Grey baby … between GA and midazolam clearance in preterm neonates (32.8 …

… These pharmacodynamic alterations influence not only the … like midazolam in preterm and
newborn infants manifesting as … Intranasal midazolam compared with intravenous diazepam …

… (2.8%): a preterm newborn with … preterm newborn who died on day 4, following grade IV
brain hemorrhage. In that case, death was attributed to brain hemorrhage and not to midazolam …

… sedation with oral midazolam versus placebo. The investigators concluded that the use of
… pharmacology of intravenous bolus and continuous infusion fentanyl use in preterm infants, …

… Clinical pharmacology of ibuprofen in preterm infants: A meta-… Clinical pharmacology of
analgesics in infants and the … and pharmacodynamics after continuous intravenous infusion of …

… , in which a child receives an oral or intravenous (IV) dose of a … In preterm neonates, the oral
bioavailability ranged from 67 to … also influence the oral bioavailability of midazolam. A study …